-
Acceptability of Early Endpoints in NICE Appraisals for Adjuvant and Neoadjuvant Oncology Therapies
Sep 9, 2025, 16:22 PM -
Analysis of the Impact of the TelE-Medicine Program for Medically Underserved Area on Hospitalization Rates Among Diabetic Patients in Medically Underserved Areas
Sep 9, 2025, 16:22 PM -
Cost Calculator of Immunotherapies in 1L Endometrial Cancer Treatment for the Deficient Mismatch Repair, Proficient Mismatch Repair, and Intention-to-Treat Populations From the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Landscape of Data Sources for Real-World Observational Studies: Focus on the French Context
Sep 9, 2025, 16:22 PM -
Economic Burden Of Primary Biliary Cholangitis (PBC) in Spain
Sep 9, 2025, 16:22 PM -
Evaluating the Potential Health and Economic Impact of V116 vs. PCV20 on Invasive Pneumococcal Disease Among Adults in the United Kingdom
Sep 9, 2025, 16:22 PM -
Artificial Intelligence in Evidence Synthesis: A Systematic Review and Meta-Analysis of Emerging Biologics for Improving Skeletal Health in Osteogenesis Imperfecta
Sep 9, 2025, 16:22 PM -
Nephrotoxicity of Antisense Oligonucleotide Therapies in Duchenne Muscular Dystrophy: A Warning or a Challenge?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of WIC Eligibility Extension in Preventing Maternal Postpartum Depression: US Payers’ Perspective
Sep 9, 2025, 16:22 PM -
Exploring Evidence Gaps in National Institute for Health and Care Excellence Early Value Assessments
Sep 9, 2025, 16:22 PM -
Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Lung Cancer Patients Using Machine Learning
Sep 9, 2025, 16:22 PM -
Global Pricing Meets Domestic Policy: Analyzing the Financial Impact of the Most-Favored Nation Approach on the United States Medicine Prices
Sep 9, 2025, 16:22 PM -
Evidence Strategy Starts Early: Integrating HTA Needs Through PICO Simulation in Metastatic Castration-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM -
Navigating Reimbursement Challenges for Pharmacological Interventions in Celiac Disease: Lessons From Analogous Conditions
Sep 9, 2025, 16:22 PM -
Evolving JCA Perspectives From EU Stakeholders and the Impact on Manufacturers
Sep 9, 2025, 16:22 PM -
Addressing the Impact of Alzheimer’s Disease on Care Capacity in the Netherlands: Implications for Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Disease Progression in Patients With Primary Hyperoxaluria: A Retrospective Cohort Study
Sep 9, 2025, 16:22 PM -
Health Equity Considerations in Economic Evaluation: Comparative Acceptability and Application Across European HTA Bodies
Sep 9, 2025, 16:22 PM -
Beyond the Mean: Do Distribution-Based Metrics Offer Greater Insight Into Predictors of Societal Health Preferences? A Secondary Analysis of 42 EQ-5D-5L Value Sets
Sep 9, 2025, 16:22 PM -
Estimating Healthcare Resource Use Associated With the Treatment of Phenylketonuria in the United States
Sep 9, 2025, 16:22 PM
